Groupe Athena, Inc. Provides Guidance on Current Orders
March 11 2014 - 9:15AM
Marketwired
Groupe Athena, Inc. Provides Guidance on Current Orders
MUMBAI, INDIA--(Marketwired - Mar 11, 2014) - Groupe Athena,
Inc. (OTC Pink: GATA) made the following announcement:
The guidance contained below represents forecasts, which
indicate possible outcomes and are provided to assist investors
with the development of earnings estimates. While Groupe Athena,
Inc. believes that these forecasts represent the best estimate of
management as to future events, actual events may differ from these
forecasts, and such differences could be material. These forecasts
are subject to risks identified under "Safe Harbor Statement"
below.
Groupe Athena, Inc. announced today they have approximately $60
million in customer orders that they are currently processing, and
they are hopeful that this number will increase in the near term.
Based on the orders in hand the company expects to be able to
convert at least one half or approximately $30 million into revenue
during the current fiscal year ending June 30, 2014. This would put
total current year revenue projections at $65,000,000, in line with
projections and provide a solid revenue base to build on for the
2015 fiscal period.
As was previously stated, the Indian pharmaceutical industry is
increasingly focusing on exports to the United States and GATA is
well positioned to help them get their products approved by the FDA
for sales in the US. The Company believes it has an advantage over
competitors due to the facilities based in India, and their ability
to deliver quick feedback to clients that could result in expedited
order generation. With recent additions to equipment, the company
will continue to take on additional contracts and continue to
anticipate further growth.
About Groupe Athena, Inc.
Groupe Athena, Inc. was incorporated in June 2008 and began
operations on July 1 of that year. The company is a research and
testing organization and helps various pharmaceutical and medical
products and devices companies in India and Southeast Asia to get
regulatory approvals and facilitate exports of their products to
the United States. The Company accomplishes this by assisting
clients from concept through development, providing consultation on
regulatory requirements, filings and processes.
The company has a research and marketing facility in India that
currently employs 19 consultants and marketing personnel and is
working towards aggressively expanding its presence in the Indian
pharmaceutical industry. The Company's web address is
www.groupeathena.com.
Safe Harbor Statement
Certain statements set forth in this press release constitute
"forward-looking statements." Forward-looking statements include,
without limitation, any statement that may predict, forecast,
indicate, or imply future results, performance or achievements, and
may contain the words "estimate", "project", "intend", "forecast",
"anticipate", "plan", "planning", "expect", "believe", "will
likely", "should", "could", "would", "may" or words or expressions
of similar meaning. Such statements are not guarantees of future
performance and are subject to risks and uncertainties that could
cause the company's actual results and financial position to differ
materially from those included within the forward-looking
statements. Forward-looking statements involve risks and
uncertainties, including those relating to the Company's ability to
grow it's business. Actual results may differ materially from the
results predicted and reported results should not be considered as
an indication of future performance. The potential risks and
uncertainties include, among others, the Company's limited
operating history, the limited financial resources, domestic or
global economic conditions, activities of competitors, the presence
of new or additional competition and conditions of equity
markets.
For more information contact: Paul Cornell
cornellpaul6@gmail.com